News Image

Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights

Provided By GlobeNewswire

Last update: Nov 5, 2024

FORT LEE, N.J., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the third quarter of 2024 and provided an update on recent business progress.

Read more at globenewswire.com

NUVECTIS PHARMA INC

NASDAQ:NVCT (6/9/2025, 11:51:17 AM)

8.65

-0.2 (-2.26%)



Find more stocks in the Stock Screener

Follow ChartMill for more